Target intelligence / Profile preview

RNA, U1 small nuclear 24, pseudogene (RNU1-24P)

Target
RNU1-24P
Molecular classification
Other (Non-coding RNA pseudogene)
01

Overview

RNU1-24P is a pseudogene belonging to the U1 small nuclear RNA (snRNA) gene family and is annotated in the human genome as a non-coding RNA[4]. Pseudogenes are gene sequences that resemble real genes but typically include base changes, deletions, or insertions that render them nonfunctional; for U1 snRNA, most pseudogenes encode imperfect or incomplete copies that neither translate into protein nor produce functional RNAs[2]. The U1 snRNA family is central to pre-mRNA splicing and transcriptome regulation[1][2], but pseudogenes like RNU1-24P by definition do not encode the functional RNA sequence nor participate in these processes[2][4]. While some pseudogenes can perform regulatory or RNA-based activities, there is currently no evidence that RNU1-24P or its transcript serves a direct biological function or acts as a pharmacological target. Its designation as a “pseudogene” means it is not a valid therapeutic target, receptor, enzyme, or transporter[2][4]. The presence and misclassification of U1 pseudogenes have been a subject of genomic annotation efforts; most do not appear transcriptionally active or functionally relevant in standard human tissues[2]. Databases including NCBI Gene and Ensembl list RNU1-24P as a pseudogene entry; there are no known therapeutic, diagnostic, or drug-interaction roles for this entity[4]. If the query is seeking a molecular target for drug development or biological assays, RNU1-24P should be excluded, as it fails to meet any criteria for a therapeutic or functional RNA target. The target name is correct per database convention, but its biological and pharmacological relevance is null.

Other names
U1.41RNU1-24P

Beyond the preview

Go deeper on RNA, U1 small nuclear 24, pseudogene (RNU1-24P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 24, pseudogene (RNU1-24P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call